Breaking News: TCRR latest news.

Over a quarter ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Options	One new option listing and three option delistings on June 6th » 08:30 06/06/23 06/06 08:30 06/06/23 08:30 RPHM Reneo Pharmaceuticals $8.55 / +0.18 (+2.15%) , KBAL Kimball International $12.31 / + (+0.00%) , DBD Diebold / + , TCRR TCR2 Therapeutics $1.51 / + (+0.00%) New option listings for… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Join Now
Earnings	TCR2 Therapeutics reports Q1 EPS ($1.03), consensus (68c) 06:35 05/11/23 05/11 06:35 05/11/23 06:35 TCRR TCR2 Therapeutics $1.97 / -0.015 (-0.76%)
Recommendations	Return of Adaptimmune assets complements TCR pipeline, says Guggenheim » 10:16 04/11/23 04/11 10:16 04/11/23 10:16 ADAP Adaptimmune $1.18 / +0.06 (+5.36%) , GSK GSK $37.62 / -0.25 (-0.66%) , TCRR TCR2 Therapeutics $1.54 / +0.065 (+4.41%) Guggenheim analyst… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Join Now
Hot Stocks	Alaunos Therapeutics appoints Hofmeister to board of directors » 07:19 03/30/23 03/30 07:19 03/30/23 07:19 TCRT Alaunos Therapeutics / + , TCRR TCR2 Therapeutics $1.45 / -0.005 (-0.34%) Alaunos Therapeutics… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Join Now
Downgrade	TCR2 Therapeutics downgraded to Neutral from Buy at Mizuho » 04:56 03/24/23 03/24 04:56 03/24/23 04:56 TCRR TCR2 Therapeutics $1.40 / -0.07 (-4.76%) , ADAP Adaptimmune $1.08 / -0.03 (-2.70%) Mizuho analyst Mara… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Join Now
Earnings	TCR2 Therapeutics reports Q4 EPS ($1.56), consensus (79c) » 06:31 03/23/23 03/23 06:31 03/23/23 06:31 TCRR TCR2 Therapeutics $1.47 / -0.075 (-4.85%) TCR2 ended the fourth… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Join Now
Downgrade	TCR2 Therapeutics downgraded to Hold from Buy at Jefferies » 05:03 03/09/23 03/09 05:03 03/09/23 05:03 TCRR TCR2 Therapeutics $1.57 / -0.07 (-4.27%) , ADAP Adaptimmune $1.22 / -0.035 (-2.80%) Jefferies analyst Kelly… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Join Now
Downgrade	TCR2 Therapeutics downgraded to Hold from Buy at Truist » 08:30 03/08/23 03/08 08:30 03/08/23 08:30 TCRR TCR2 Therapeutics $1.64 / + (+0.00%) , ADAP Adaptimmune $1.25 / -0.06 (-4.58%) As previously reported,… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Join Now
Downgrade	TCR2 Therapeutics downgraded to Hold from Buy at Truist » 14:22 03/07/23 03/07 14:22 03/07/23 14:22 TCRR TCR2 Therapeutics $1.67 / +0.03 (+1.83%) Truist analyst Asthika… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Join Now
Downgrade	TCR2 Therapeutics downgraded to Neutral from Buy at H.C. Wainwright » 06:10 03/07/23 03/07 06:10 03/07/23 06:10 TCRR TCR2 Therapeutics $1.63 / +0.45 (+38.14%) , ADAP Adaptimmune $1.31 / -0.42 (-24.28%) H.C. Wainwright analyst… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Join Now

16:41	What You Missed On Wall Street On Friday»
15:59	Bet On It: Genius Sports introduces BetVision with NFL live games in U.S.»
15:43	Buy/Sell: Wall Street's top 10 stock calls this week»
14:15	Short Report: Bears reduce exposure to crypto names»
12:00	What You Missed On Wall Street This Morning»

Get Full Fly Access